NCT05740839 2026-02-24
HYPE
Dana-Farber Cancer Institute
Phase NA Recruiting
Clinical Trials
5 trialsNCT07321353 2026-01-07
SJ
Children's Hospital Medical Center, Cincinnati
Phase NA Recruiting
NCT05521984 2025-12-08
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Washington University School of Medicine
Phase 1 Recruiting
NCT03591861 2022-12-12
Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
Washington University School of Medicine
Phase NA Terminated
NCT03068832 2021-05-25
Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
Washington University School of Medicine
Phase 1 Withdrawn